Boston Scientific Acquires Axonics for $3.7B to Expand Urology Portfolio
- Nov 20, 2024
- 1 min read
Marlborough, MA, November 15, 2024 (PRNewswire) -- Boston Scientific has acquired Axonics for $3.7 billion, expanding its Urology business into sacral neuromodulation. The acquisition enhances Boston Scientific’s portfolio of products for treating urinary and bowel dysfunction.
Read full article here.
Comments